Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients.
about
Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic DrugsOlder age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis.Inflammatory bowel disease of the elderly: frequently asked questions (FAQs).Management of the elderly patients with inflammatory bowel disease: practical considerations.Rheumatoid arthritis in the elderly in the era of tight control.Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceSafety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.Response rates of three modes of survey administration and survey preferences of rheumatoid arthritis patients.RABBIT risk score and ICU admission due to infection in patients with rheumatoid arthritis.Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registry.Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis.Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment.Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate-to-Severe Rheumatoid Arthritis.Biologic treatments for elderly patients with psoriasis.Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies.[Safety of antirheumatic drug treatment in the elderly].
P2860
Q28073436-23E248C3-C8B6-4D0D-9CD4-7B4F7BB1DFA2Q36028729-E5B75FFA-5472-4F57-B50D-2E5F7771B7D0Q36099620-0FE0B3A9-432E-4CE8-B395-C6AE50708C2CQ37921606-ABD507FA-73ED-4488-9F51-DE284270EB28Q38122069-DA48E9D6-5BA1-431F-8F8B-79B17ADE4984Q38150731-567F8239-9E7B-41AD-81E4-7F3FBB2C84A2Q38476881-D58CCB02-9BC3-4648-9FC9-F09ECD2C31FDQ38827889-FB4717DA-4A25-47C2-B49A-21E3EB5B3814Q38995105-1F9548F8-48C6-46B1-BCC5-679073A59A65Q39360324-55452316-0B59-4ACF-BBA6-9C41EFDB4D70Q40047290-241A9866-22A5-4F68-AAAA-045C345BEF5CQ41709276-D263EF7D-76A7-44C8-ADED-510B63EBEEC2Q42701803-2CAF4772-E555-48B7-AF54-46A1306EAC72Q47120472-B48148B1-014C-460E-8F8F-A99B62716191Q47918450-B20E31E9-35D2-4745-8D1C-944B7DE5B393Q48236525-B8A80F30-14DC-43AF-A488-6495B9184846Q50495423-33C0E7F3-3421-496B-AF90-8FE68C347800Q52878034-3C708C65-3173-4EA0-AE49-CBA0C8631BB3
P2860
Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Response of elderly patients w ...... ompared with younger patients.
@en
Response of elderly patients w ...... ompared with younger patients.
@nl
type
label
Response of elderly patients w ...... ompared with younger patients.
@en
Response of elderly patients w ...... ompared with younger patients.
@nl
prefLabel
Response of elderly patients w ...... ompared with younger patients.
@en
Response of elderly patients w ...... ompared with younger patients.
@nl
P2093
P2860
P356
P1433
P1476
Response of elderly patients w ...... ompared with younger patients.
@en
P2093
Aileen Pangan
Daniel Aletaha
Daniel Baker
Julia Funovits
Marcus D Köller
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEP291
P577
2009-10-07T00:00:00Z